Online Continuing Professional Development Courses
CSEM 2021 Knowledge Transfer Activities
Register today for the 2021 Knowledge Transfer Activities (KTAs).
KTA #1 — Growth Hormone Deficiency: New Options for Treatment & Long-Acting Therapies
Wednesday, April 14, 2021 | 7:00–9:00 pm ET | Section 3 credits
Dr. Elizabeth Rosolowsky, MD, MPH, FAAP, FRCPC, University of Alberta (chair)
Dr. Cheri Deal, PhD, MD, FRCPC, CHU Ste. Justine
Dr. Rose Girgis, MBBCh, MSc, FRCPC, University of Alberta
Do you prescribe growth hormone? Do you wonder why some kids seem to respond better to growth hormone therapy than others? Do you hear from patients that they wish there were fewer injections? Have you been wondering, "what's the latest on long-acting growth hormone formulations?"
If you answered YES to these questions, then we have the seminar for you! Please join us for an engaging, interactive presentation and discussion on advances in growth hormone therapy. Our speakers, Dr. Cheri Deal and Dr. Rose Girgis, have both been directly involved in the pivotal long-acting growth hormone trials.
- Outline the steps for initiation of growth hormone treatment and evaluation of response
- Discuss barriers that limit adherence to GH replacement treatments and strategies to mitigate them
- Compare and contrast the efficacy of daily versus long-acting rGH treatments in pediatric GH deficiency
KTA #2 — Androgen Misuse and Abuse
Wednesday, April 28, 2021 | 7:00–9:00 pm ET | Section 3 credits
Dr. Adam Millar, MD, MScCH, FRCPC, University of Toronto (chair)
Dr. Richard Auchus, MD, PhD, University of Michigan
Dr. Bradley Anawalt, MD, University of Washington Medical Center, University of Washington
Do you know that 1-5% of men are believed to have used androgenic anabolic steroids at some point in their life? Are you aware that these individuals will often use doses 10 to 100 times higher than typical replacement doses? Misuse and abuse of androgens is an increasing concern in healthcare today and poses many challenges for the practicing endocrinologist. This KTA features international experts to help us navigate this complicated topic, by addressing the following objectives:
- Discuss laboratory features suggestive of androgen misuse/abuse
- Discuss impact of androgen misuse/abuse including hypogonadism in men
- Identify counseling strategies for patients
- Recognize key considerations for endocrinologists when consulted by family physicians
Dr. Richard Auchus is a Professor of Internal Medicine, Professor of Pharmacology, and James A Shayman and Andrea S Kevrick Professor of Translational Medicine at the University of Michigan. He will be sharing real-life patient cases on the topic of androgen misuse and abuse.
Dr. Bradley Anawalt is the Chief of Medicine at the University of Washington Medical Center and Professor and Vice Chair of the Department of Medicine at the University of Washington, and he will discuss the impact of androgen abuse and misuse in men, strategies for counselling patients and key considerations for management.
Please join us for this interactive and in-depth discussion on this challenging and controversial topic.
KTA #3 — Challenging Diabetes: Hyperglycemia in Cushing’s and Acromegaly
Wednesday, May 12, 2021 | 7:00–9:00 pm ET | Section 3 credits
Dr. Ally Prebtani, MD, FRCPC, McMaster University (chair)
Dr. Carly Brescacin, PsyD, CPsych, Clinical and Health Psychologist, The Downtown Psychology Clinic, Toronto
Dr. Ehud Ur, MB, FRCPC, University of British Columbia
- Describe the unique challenges of managing diabetes in Cushing’s Syndrome and Acromegaly
- Describe how treatment of Cushing’s Disease and Acromegaly can affect glycemia
- Apply motivational interviewing techniques to support improved health and well-being
- Recognize the importance of multi-disciplinary approach
Endocrine Society ESAP Courses
These programs are designed to further the knowledge of healthcare professionals with the ultimate goal of improving patient care. Note: you must be logged into mdBriefCase's website to access these courses. Registration is free to CSEM members.